Inseron

Inseron was a small private biotechnology company focused on developing genetic biomarkers, gene expression tools, and pathway profiling technologies for drug discovery and translational research. Publicly available information indicates the company provided molecular tools to study gene expression and function and appears to have operated more as a discovery-enabling platform and research tools company than as a clinical therapeutics developer. Historical references tie the company to work on optimized green fluorescent protein technologies and related biomarker applications. The business appears to be inactive today, with only legacy web, patent, and corporate-registration traces readily discoverable. No clear evidence was found of an active clinical pipeline, commercial drug portfolio, or acquisition by a larger biopharma company.